Strong Performance for Dräger in First Half of 2026

Drägerwerk AG & Co. KGaA reported a solid business performance during the first half of 2026, with order intake slightly surpassing the previous year's level, net sales rising sharply, and significant earnings improvement. The company's earnings before interest and taxes (EBIT) increased by EUR 43 million to EUR 63.8 million. This was driven by strong performance in medical and safety divisions, and a refund of U.S. customs duties.

Despite challenges in the Americas region, order intake rose by 1.8 percent, driven mainly by growth in Germany and the EMEA region. The safety division showed a notable order intake increase of 9.5 percent.

Net sales saw a 7.7 percent increase across both divisions, supported by growth in the EMEA and Americas regions. The German market showed a noticeable sales boost. The forecast for the EBIT margin for 2026 has been revised upwards to 6.0 to 8.0 percent, benefiting from customs refunds and strong operating performance.